Botulinum Toxin A and Lower Urinary Tract Dysfunction: Pathophysiology and Mechanisms of Action
The use of onabotulinumtoxinA (BoNT-A) for the treatment of lower urinary tract diseases (LUTD) has increased markedly in recent years. The indications for BoNT-A treatment of LUTD now include neurogenic or idiopathic detrusor overactivity, interstitial cystitis/bladder pain syndrome and voiding dys...
Збережено в:
| Автори: | , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
MDPI AG
2016-04-01
|
| Серія: | Toxins |
| Предмети: | |
| Онлайн доступ: | http://www.mdpi.com/2072-6651/8/4/120 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|